What Does MFX Do?

Total employees43
HeadquartersWest Chester
Founded2020

MFX Biotherapeutics (operating as mfxbio) is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative targeted therapies. Their primary focus is on oncology, aiming to address unmet medical needs in cancer treatment. By leveraging advanced scientific understanding and cutting-edge technologies, mfxbio strives to improve patient outcomes in various debilitating diseases.

Where Is MFX's Headquarters?

HQ Function

Serves as the central hub for research and development, clinical trial management, strategic planning, and corporate administration.

Notable Features:

Likely equipped with modern laboratory facilities for biopharmaceutical research, cell culture suites, and collaborative office spaces designed to foster innovation. Specific architectural details are not publicly highlighted.

Work Culture:

A dynamic and intellectually stimulating environment, characterized by a strong emphasis on scientific rigor, innovation, collaboration among multidisciplinary teams, and a shared commitment to advancing patient care through targeted therapies.

HQ Significance:

Strategically located in West Chester, Pennsylvania, part of the Greater Philadelphia life sciences corridor, providing access to a rich ecosystem of talent, research institutions, and potential collaborators. Its location supports its mission to advance cutting-edge biotherapeutics.

Values Reflected in HQ: The headquarters likely reflects mfxbio's core values of innovation (through R&D spaces), precision (in lab design and operations), and collaboration (through workspace design).

Location:

mfxbio's operations are primarily centered in the United States, focusing on research, development, and clinical trials. While direct global offices are not prominent, the company may engage in international collaborations for research, participate in global scientific conferences, and potentially seek regulatory approvals and partnerships in key international markets as its therapeutic candidates advance.

Street Address:

975 Andrew Drive

City:

West Chester

State/Province:

PA

Country:

USA

Where Else Does MFX Operate Around the World?

No additional office locations available.

Buying Intent Signals for MFX

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading MFX? Meet the Executive Team

As of April 2025, MFX' leadership includes:

Chris Pak, Ph.D. - President & CEO
Brian Gray, Ph.D. - Chief Scientific Officer

Who's Investing in MFX?

MFX has been backed by several prominent investors over the years, including:

Molecular Targeting Technologies, Inc. (MTTI)
Private Investors (assumed, typical for spin-outs)

What Leadership Changes Has MFX Seen Recently?

Hire0
Exits0

Based on publicly available information, there have been no major executive hires or exits publicly announced by mfxbio in the last 12 months. The leadership team appears stable.

What Technology (Tech Stack) Is Used byMFX?

Discover the tools MFX uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

MFX Email Formats and Examples

mfxbio likely uses common corporate email formats. Based on the company domain mfxbiotherapeutics.com, a probable format is the first initial followed by the last name.

[first_initial][last]@mfxbiotherapeutics.com

Format

jdoe@mfxbiotherapeutics.com

Example

85%

Success rate

What's the Latest News About MFX?

mfxbiotherapeutics.comMarch 25, 2024

mfxbio to Present at the 2024 AACR Annual Meeting

MFX Biotherapeutics announced its upcoming presentation at the American Association for Cancer Research (AACR) Annual Meeting 2024, where it will share new data on its therapeutic candidates....more

mfxbiotherapeutics.comDecember 12, 2023

mfxbio Highlights Positive Preclinical Data for EvaCTX™ Program at the 2023 San Antonio Breast Cancer Symposium

MFX Biotherapeutics presented promising preclinical findings for its EvaCTX™ (evofosfamide) program in combination therapy for hypoxic solid tumors at the San Antonio Breast Cancer Symposium (SABCS)....more

mfxbiotherapeutics.comApril 3, 2023

mfxbio Announces FDA Clearance of IND Application for a Phase 1/2 Clinical Trial of EvaCTX™ (Evofosfamide) in Combination with Pembrolizumab

MFX Biotherapeutics received Investigational New Drug (IND) application clearance from the U.S. Food and Drug Administration (FDA) to proceed with a Phase 1/2 clinical trial evaluating EvaCTX™ (evofosfamide) in combination with pembrolizumab for patients with specific types of solid tumors....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including MFX, are just a search away.